Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by SheerBolshevikon Dec 19, 2017 9:04am
146 Views
Post# 27185326

RE:Countdown begins

RE:Countdown begins
suncapital wrote: THC has to release something in the next few days one way or another. We have to start over $1 in 2018, or something definitely is wrong (ie, manipulation) I am going to visit THC personally if we are not in $2+ range by early Feb, we should be looking at close to $5 range by May or June. This is within 6X return range Malex1 is looking for. John has not failed us yet and I do believe that he will come through. Whether we reach this number or not, my clients are not happy with THCs PR/IR anyway so countdown begins!!! Asia ETFs are picking up on MJ index trading which is good news if THC can somehow be in the basket. $5 was the initial target prior to the D day for us, and this should give $500 million market cap for THC. Beyond this number, we need to seriously think about new management governance which will be part of our proposal six months from now. If you are long on THC, hang in there.


Its getting very difficult to sit here day after day watching the SP erode...again Simple things can be done to at least keep the SP buoyant, but nothing is being done. Very frustrating John Miller
Bullboard Posts